Uncategorized

Section 174 R&E Capitalization: The 5/15-Year Amortization, OBBBA Repeal Status, Worked Example

By chrisomo

Section 174 capitalization forces every U.S. business that incurs research and experimental costs to spread those costs across 5 years for domestic work or 15 years for foreign work, rather than deducting them in the year paid. The rule kicked in for tax years beginning after December 31, 2021 under the Tax Cuts and Jobs Act of 2017 (Public Law 115-97, §13206). The One Big Beautiful Bill Act, signed July 4, 2025, restored full domestic expensing prospectively while preserving 15-year amortization for foreign research, ending nearly four years of working-capital pain for U.S. R&E-heavy companies.

What is Section 174 capitalization?

IRC §174 defines the federal tax treatment of “specified research or experimental expenditures.” Before 2022, taxpayers could fully deduct R&E in the year incurred under prior §174(a)(1) or elect 60-month amortization under prior §174(b). The TCJA of 2017, at §13206, replaced both options with mandatory amortization: 5 years for domestic SRE, 15 years for foreign SRE, with the half-year convention applied in year one (current §174(a)(2)(B)). The rule took effect for tax years beginning after December 31, 2021. The OBBBA of 2025 reopened immediate expensing for domestic SRE only, leaving the foreign 15-year rule in place. The change is significant: a $1,000,000 domestic R&E spend in 2023 produced only a $100,000 first-year deduction instead of the full $1,000,000 available pre-TCJA.

Why Section 174 capitalization matters

The shift from expensing to capitalization moves cash out the door without a corresponding deduction. For a venture-backed software company spending $5 million on engineering payroll in 2023, the §174(a)(2)(B) rule allowed only $500,000 deductible in 2023 (half-year convention), forcing the company to recognize $4.5 million in additional taxable income relative to the pre-TCJA baseline. At a 21% federal corporate rate, that’s a $945,000 federal tax acceleration in a single year. State conformity varies: California fully conforms to the federal §174 rule for tax years beginning after December 31, 2021 (Cal. Rev. & Tax Code §17201, §24349). Texas, Wyoming, and South Dakota have no corporate income tax, so the impact is federal-only. The OBBBA reset, effective for tax years beginning after December 31, 2024, restores the prior expensing regime for domestic SRE prospectively, with elective catch-up treatment for unamortized 2022-2024 balances.

The accounting consequences extend beyond cash tax. Under ASC 740, the §174 capitalization rule created a substantial deferred tax asset (DTA) for software and biotech companies starting with their 2022 financial statements: the book treatment of R&E expense (immediately expensed under ASC 730 or capitalized under specific software cost guidance) diverged from the tax treatment of mandatory §174 amortization. For pre-revenue startups, the DTA was almost always paired with a full valuation allowance under ASC 740-10-30-17, producing a zero net impact on book income but a meaningful disclosure in the rate reconciliation. For profitable mid-market companies, the DTA created an asset on the balance sheet that flowed through to deferred tax provision benefits and required ongoing measurement under ASC 740-10-30-5 each reporting period. The OBBBA reset in 2025 reverses this dynamic for new domestic spending, but leaves the legacy DTA in place for unamortized 2022-2024 balances at most large taxpayers.

How Section 174 capitalization works (mechanics)

For tax years beginning after December 31, 2021 and before January 1, 2025, every dollar of SRE must be capitalized and amortized. The mechanics break down as follows. First, identify SRE costs. Under Reg. §1.174-2 as updated by Notice 2023-63, SRE includes wages paid to employees performing qualified research, supplies consumed in research, contract research costs, and software development costs under IRC §174(c)(3). Second, classify each dollar as domestic or foreign. Wages paid to a U.S.-based engineer are domestic. Wages paid to a contractor in Vietnam are foreign. Third, apply the half-year convention. The amortization period begins at the midpoint of the tax year in which the SRE is paid or incurred under §174(a)(2)(B)(ii). For a calendar-year taxpayer, the first-year deduction is one-tenth (1/10) for domestic SRE and one-thirtieth (1/30) for foreign SRE. Fourth, continue amortization in subsequent years until the cost is fully recovered. The OBBBA of 2025, at §70302, added new IRC §174A allowing immediate deduction of domestic SRE for tax years beginning after December 31, 2024. Foreign SRE remains under §174(a)(2)(B) at 15-year amortization indefinitely.

Identification of SRE in practice requires a methodology choice. The two common approaches are (a) the project-by-project methodology, which traces each engineering project’s wages, supplies, and contract costs into a §174 pool, and (b) the cost-center methodology, which treats the entire engineering or R&D department’s cost base as SRE with corrections for non-qualified activity (administrative time, support, training). Notice 2023-63 §7 endorses both methodologies but requires reasonable consistency from year to year. Wage allocation methodologies under the §41 R&D credit (the four-part test in IRC §41(d)) generally do not carry over directly to §174 because §174 has a broader scope: §41 requires “qualified research” meeting a process-of-experimentation test, while §174 covers any activity treated as research or experimentation in the experimental or laboratory sense, including software development per §174(c)(3). A typical software company captures only 60-70% of its engineering headcount under §41 but 85-95% under §174.

Section 174 amortization periods at a glance

Worked example

Consider DataForge Analytics LLC, a Delaware C-corporation with calendar year-end and average gross receipts of $42 million (above the §448(c) small business threshold). DataForge spent $3,000,000 on domestic engineering wages and $500,000 on a contract development team in Poland during 2023. Under IRC §174(a)(2)(B), DataForge must capitalize both amounts. For 2023, with the half-year convention, the deduction is $3,000,000 / 5 / 2 = $300,000 for domestic SRE plus $500,000 / 15 / 2 = $16,667 for foreign SRE, total $316,667 deductible against a $3,500,000 cash outlay. Years 2024 through 2027 each pick up $600,000 in domestic amortization plus $33,333 in foreign amortization. Year 2028 picks up the final half-year on the domestic side ($300,000) plus continued foreign amortization. Foreign amortization continues through year 2038. The Section 41 R&D credit interaction matters: DataForge can still claim a §41 credit on the same $3,500,000 in qualified research expenditures, but Reg. §1.280C-4 forces a reduced credit election or an addback to income equal to the credit. If DataForge claims a $200,000 §41 credit and does not elect reduced credit, $200,000 of the §174 amortization base is treated as a deemed expense, with the credit added to gross income that year.

Recent changes (OBBBA, TCJA)

The TCJA of 2017 at §13206 created the §174 capitalization regime, effective for tax years beginning after December 31, 2021. Congressional debate around restoration began almost immediately after the rule took effect in 2022, with the bipartisan Tax Relief for American Families and Workers Act of 2024 (H.R. 7024) passing the House in January 2024 but stalling in the Senate. The One Big Beautiful Bill Act (Public Law 119-21), signed by the President on July 4, 2025, ultimately resolved the §174 question through §70302. The OBBBA enacted new IRC §174A providing for full immediate deductibility of domestic SRE for tax years beginning after December 31, 2024. Foreign SRE continues under §174(a)(2)(B) at 15-year amortization. Small businesses meeting the §448(c) gross receipts test (currently $31 million for 2025 under Rev. Proc. 2024-40) may elect catch-up recovery of unamortized 2022-2024 domestic SRE in the first tax year beginning after December 31, 2024 under OBBBA §70302(f). Other taxpayers continue amortizing pre-2025 balances over the original 5-year schedule. Notice 2025-89, issued by the IRS in November 2025, provides transition procedures including an automatic accounting method change under Rev. Proc. 2025-23.

Common pitfalls

• Treating software development as deductible. IRC §174(c)(3) explicitly defines all software development as SRE regardless of internal-use status. Custom-built ERP implementations, mobile apps, AI model training pipelines, and SaaS feature work all require §174 capitalization. Reg. §1.174-2(a)(11) details the activities covered.
• Missing the foreign-versus-domestic classification. Under IRC §174(a)(2)(B)(i), foreign SRE is research performed outside the United States, Puerto Rico, or any U.S. possession. Wages paid to a U.S. citizen working remotely in Lisbon count as foreign SRE. Notice 2023-63 §4 details the geographic sourcing rules.
• Failing to recapture on disposition. Under IRC §174(d) and Reg. §1.174-2(b), unamortized SRE survives sale or abandonment of the underlying property and must continue amortizing or be recognized as a §165 loss only if the project is fully abandoned, not merely sold.
• Stacking §174 capitalization with reduced §41 credit elections incorrectly. IRC §280C(c) requires either a reduced §41 credit or an addback to taxable income. Taxpayers who fail to make the §280C(c) election on a timely-filed return (including extensions) lose access to the reduced credit option for that year.
• Forgetting state nonconformity. Pennsylvania (72 P.S. §7401), Tennessee, and Massachusetts each adopted varying degrees of conformity to the federal §174 rule, with some states still allowing full expensing. State-level analysis must be done separately for every jurisdiction where the taxpayer files.
• Mishandling Notice 2023-63 transition procedures. The IRS released Notice 2023-63 on September 8, 2023 providing interim guidance on §174 application. Taxpayers who filed 2022 returns before September 8, 2023 may need superseding returns or accounting method changes under Rev. Proc. 2023-11 to reflect the guidance.
• Assuming OBBBA repealed §174 retroactively. The OBBBA restored domestic expensing prospectively for tax years beginning after December 31, 2024, with elective catch-up only for small businesses meeting the §448(c) test. Large taxpayers continue amortizing 2022-2024 domestic balances on the original 5-year schedule.

Frequently asked questions

Did the OBBBA repeal Section 174 capitalization?

A. The OBBBA, signed July 4, 2025, restored immediate deductibility of domestic SRE prospectively for tax years beginning after December 31, 2024, by enacting new IRC §174A. It did not repeal §174. Foreign SRE remains subject to 15-year amortization under IRC §174(a)(2)(B). Large taxpayers with unamortized 2022-2024 domestic SRE balances continue amortizing on the original 5-year schedule. Only small businesses meeting the §448(c) gross receipts test (currently $31 million) may elect catch-up recovery of the unamortized balance in their first 2025 tax year, under OBBBA §70302(f).

Does Section 174 capitalization apply to software development costs?

A. Yes. IRC §174(c)(3) explicitly defines all software development costs as specified research or experimental expenditures, with no carve-out for internal-use software, custom software, or commercially marketed software. Reg. §1.174-2(a)(11) provides detailed activity definitions, including coding, testing, design, and de-bugging. Notice 2023-63 §5 confirms that costs incurred to “develop” software fall within §174 even if the resulting software is acquired by a third party as a service.

How does Section 174 interact with the Section 41 R&D credit?

A. Every dollar claimed as qualified research expenditure (QRE) under IRC §41 must also be capitalized under §174. The two rules run in parallel. To avoid double-counting, IRC §280C(c) requires the taxpayer either to elect a reduced §41 credit (currently the gross credit times 1 minus the corporate rate) or to include the gross credit in income. Notice 2023-63 §3 confirms that the §41 credit base remains intact, but the §174 amortization period applies to the underlying expenses regardless of credit treatment.

What is the half-year convention under Section 174?

A. IRC §174(a)(2)(B)(ii) requires that amortization of SRE begin at the midpoint of the tax year in which the expenditure is paid or incurred. For a calendar-year taxpayer, that means the first-year deduction equals one-half of one year’s ratable share. Domestic SRE is recovered at 1/10 in year one and 1/5 in years two through five, with the final 1/10 in year six. Foreign SRE is recovered at 1/30 in year one and 1/15 in years two through fifteen, with the final 1/30 in year sixteen.

Can a small business catch up Section 174 amortization in 2025?

A. Yes, but only if the taxpayer meets the §448(c) gross receipts test (average annual gross receipts of $31 million or less for 2025, under Rev. Proc. 2024-40). OBBBA §70302(f) allows eligible small businesses to elect first-year recovery of all unamortized domestic SRE balances from 2022-2024 in the first tax year beginning after December 31, 2024. The election is made on a timely-filed 2025 return. Foreign SRE balances are not eligible for catch-up. Larger taxpayers continue the original 5-year amortization schedule for legacy domestic balances.

What happens to Section 174 capitalized costs when a research project is abandoned?

A. Under IRC §174(d) and Reg. §1.174-2(b)(4), the unamortized portion of SRE is not deductible upon sale or other disposition of the underlying property. The taxpayer must continue amortizing under the original schedule. If the project is fully abandoned and the taxpayer can document that the research has no remaining value, an IRC §165 loss may be claimed on the unamortized balance. The standard for abandonment is high and requires contemporaneous documentation.

How do contract research arrangements interact with Section 174?

A. Under Reg. §1.174-2(a)(7), the party economically bearing the risk of research failure capitalizes the SRE. If a sponsor pays a contract research organization (CRO) on a fixed-fee basis where the CRO bears no risk, the sponsor capitalizes the full amount under §174. If the contract is structured so the CRO bears the risk of failure (true research-for-hire), the CRO capitalizes. Notice 2023-63 §6 provides additional guidance on the funded research analysis from Reg. §1.41-4A(d).

Does Section 174 apply to startups before they have revenue?

A. Yes. IRC §174 applies regardless of whether the taxpayer has begun generating revenue. Pre-revenue startups incurring engineering wages and contract research costs must capitalize those amounts and begin amortization at the midpoint of the year incurred. The capitalized SRE creates a deferred tax asset under ASC 740 (the timing difference between book and tax). For startups with operating losses, this often produces a paper tax liability before the company has positive cash flow, a phenomenon widely reported in 2022-2024 startup tax filings.

How does Section 174 apply to acquired in-process research and development (IPR&D)?

A. When a corporation acquires another business in a transaction that produces a basis step-up (asset purchase or Section 338(h)(10) election), the acquired SRE is typically reflected as in-process research and development under ASC 805. The tax treatment differs from book. Under Reg. §1.174-2(b), the acquired IPR&D basis is amortized over the same §174 periods (5-year domestic, 15-year foreign) if the acquirer continues the research. Acquired patents and existing technology are amortized under IRC §197 over 15 years, not §174. The distinction can be significant in a worked allocation: see our coverage of accounting for business combinations for fuller treatment of the §174 versus §197 boundary in M&A allocations.

What is the accounting method change procedure for Section 174?

A. Rev. Proc. 2023-11 (and superseding Rev. Proc. 2025-23 issued in connection with the OBBBA transition) provides automatic accounting method change procedures for taxpayers moving onto or off of §174 capitalization. The taxpayer files Form 3115 with their tax return for the year of change. The change is made on a cut-off basis for the §174(a)(2)(B) adoption (2022 onward) and on a §481(a) basis for certain OBBBA transition elections. Form 3115 must be filed in duplicate: one copy with the tax return, one copy with the Ogden, Utah service center.